Edging Lobelia
Lobelia Erinus

Medicinal Facts
Lobelia erinus, commonly known as Edging Lobelia, is primarily noted for its alkaloid content, particularly lobeline, which has been studied for its respiratory and neurological effects. This plant sits at the intersection of traditional herbal smoking cessation aids and modern pharmacological research into dopamine and nicotinic acetylcholine receptor modulation. Its role in respiratory health and potential neuroprotective effects are of particular interest, though its use is tempered by concerns over toxicity at higher doses.
What it helps with
Respiratory health
Lobeline, the primary alkaloid in Lobelia erinus, acts as a partial agonist at nicotinic acetylcholine receptors and modulates dopamine release. This dual action can help facilitate bronchodilation and expectoration, traditionally used to support asthma and bronchitis. Evidence is primarily from traditional use and preclinical models, with limited human trials.
Smoking cessation
Lobeline's ability to modulate dopamine release and act on nicotinic receptors has been explored as a potential aid in smoking cessation. It mimics some of the effects of nicotine, reducing withdrawal symptoms and cravings. The evidence is mixed, with some small human trials and animal studies supporting its use, but concerns over side effects limit its widespread adoption.
Neurological health
Lobeline may exert neuroprotective effects through its modulation of dopamine pathways and inhibition of dopamine transporter activity. This action suggests potential benefits in conditions like Parkinson's disease, though evidence is largely preclinical. Its ability to reduce oxidative stress via Nrf2 activation is also under investigation.
Inflammation
Lobeline has been shown to inhibit the release of pro-inflammatory cytokines such as TNF-alpha and IL-6 in vitro. This anti-inflammatory action may contribute to its traditional use in respiratory conditions, though direct evidence in humans is lacking.
Pain management
Lobeline's interaction with nicotinic receptors may also influence pain perception, as these receptors are involved in the modulation of pain pathways. Animal models suggest potential analgesic effects, but human data are sparse.
Mood regulation
The modulation of dopamine pathways by lobeline suggests potential applications in mood disorders. By influencing dopamine and serotonin levels, it may help alleviate symptoms of depression and anxiety, though clinical evidence is preliminary.
Weight management
Lobeline has been investigated for its potential to suppress appetite and reduce food intake by modulating dopamine and nicotinic receptors. Animal studies suggest a possible role, but human trials are needed to confirm efficacy and safety.
Key active compounds
Lobeline
An alkaloid that acts as a partial agonist at nicotinic acetylcholine receptors and modulates dopamine release. It has been studied for its potential in smoking cessation and respiratory support, though its use is limited by potential toxicity.
Lobelanidine
A secondary alkaloid with similar but less potent effects compared to lobeline. It contributes to the overall pharmacological profile of Lobelia erinus.
Lobelanine
Another alkaloid present in Lobelia erinus, it may have synergistic effects with lobeline, enhancing its respiratory and neurological actions.
Flavonoids
These compounds provide antioxidant benefits, potentially reducing oxidative stress and contributing to the plant's anti-inflammatory properties.
Saponins
Known for their ability to enhance the absorption of other compounds, saponins in Lobelia erinus may improve the bioavailability of its alkaloids.
Phenolic acids
These compounds offer additional antioxidant properties, supporting the plant's traditional use in inflammatory conditions.
What the research says
Research into Lobelia erinus focuses on its alkaloid content, particularly lobeline, which has shown promise in modulating nicotinic receptors and dopamine pathways. Human studies on smoking cessation provide some evidence of efficacy, though results are inconsistent and often overshadowed by safety concerns. Preclinical studies highlight potential neuroprotective and anti-inflammatory effects, but these findings have yet to be robustly translated into clinical settings. The primary limitation remains the potential toxicity of lobeline, which necessitates careful dosing and has led to a focus on safer derivatives or formulations that mitigate adverse effects.
Typical dosage
For tea or infusion, use 1 teaspoon of dried Lobelia Erinus leaves per cup of boiling water, steep for 10 minutes, and consume up to twice daily. For tinctures, a typical dosage might be 5-10 drops diluted in water, taken up to three times daily. Capsules should be taken as directed on the product label, usually not exceeding 100 mg per day. Always start with the lowest dose and consult a healthcare provider before use.
About Edging Lobelia
Traditional Use
Preparations & Dosage
Preparations
- Tea / Infusion: Use 1 teaspoon of dried Lobelia Erinus leaves per cup of boiling water. Steep for 10 minutes, strain, and drink. Add honey or lemon for taste if desired.
- Tincture: Use a dropper to measure 5-10 drops of Lobelia Erinus tincture into a glass of water. Stir and consume up to three times daily.
- Capsule: Take one capsule of Lobelia Erinus extract, typically 50-100 mg, with water. Follow the dosage instructions on the product label.
Interactions & Warnings
Use with caution
Lobelia Erinus should be used with caution as it can be toxic in high doses. It is not recommended for pregnant or breastfeeding women, and individuals with heart conditions should avoid it. Always consult with a healthcare provider before use.
Herb Interactions
May enhance sedative effects when combined, leading to increased drowsiness.
Community Plants
Real plants of this species grown and shared by the MyFloralVault community.
More in Respiratory Health
Was this helpful?
0 · 0








